
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Speaker Programs from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/speaker-programs/topic/22057/</link>
        <description>Articles tagged with Speaker Programs from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Navidea deploying MSLs in launch of new diagnostic agent</title>
          <description>Medical science liaisons will educate nuclear-medicine clinicians as part of the launch of a new Navidea diagnostic agent for use in breast and skin cancer.</description>
          <link>http://www.mmm-online.com/navidea-deploying-msls-in-launch-of-new-diagnostic-agent/article/291661/</link>
          <pubDate>Thu, 02 May 2013 16:15:10 GMT</pubDate>
          <itunes:summary>Medical science liaisons will educate nuclear-medicine clinicians as part of the launch of a new Navidea diagnostic agent for use in breast and skin cancer.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Breakup, Xeljanz plans dominate Pfizer earnings call</title>
          <description>Sales slipped 9% during the quarter, compared to the same period last year, but analysts zeroed in on if and when the company will split and how arthritis pill Xeljanz will tackle Europe.</description>
          <link>http://www.mmm-online.com/breakup-xeljanz-plans-dominate-pfizer-earnings-call/article/291220/</link>
          <pubDate>Tue, 30 Apr 2013 16:32:13 GMT</pubDate>
          <itunes:summary>Sales slipped 9% during the quarter, compared to the same period last year, but analysts zeroed in on if and when the company will split and how arthritis pill Xeljanz will tackle Europe.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Novartis sued for alleged speaker-program abuse</title>
          <description>The Swiss drug maker is defending itself against two civil fraud lawsuits filed within a week of each other.</description>
          <link>http://www.mmm-online.com/novartis-sued-for-alleged-speaker-program-abuse/article/291064/</link>
          <pubDate>Mon, 29 Apr 2013 20:00:47 GMT</pubDate>
          <itunes:summary>The Swiss drug maker is defending itself against two civil fraud lawsuits filed within a week of each other.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Business briefs: Reps mum on adverse events; FCC&apos;s new mHealth director; med schools tighten speaking limits</title>
          <description>A study finds sales reps find time to talk benefits, but not risks, even when touting black-box drugs; FCC has named its new mHealth director; pharma scaled back its food budgets last year; and AMSA says 18 med schools now ban faculty from speakers bureau participation</description>
          <link>http://www.mmm-online.com/business-briefs-reps-mum-on-adverse-events-fccs-new-mhealth-director-med-schools-tighten-speaking-limits/article/288466/</link>
          <pubDate>Thu, 11 Apr 2013 18:05:09 GMT</pubDate>
          <itunes:summary>A study finds sales reps find time to talk benefits, but not risks, even when touting black-box drugs; FCC has named its new mHealth director; pharma scaled back its food budgets last year; and AMSA says 18 med schools now ban faculty from speakers bureau participation</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>ProPublica&apos;s Charles Ornstein on life beyond Sunshine</title>
          <description>What will become of Dollars for Docs after the Sunshine provisions go into effect? We asked Charles Ornstein, who told us what&apos;s next for the project.</description>
          <link>http://www.mmm-online.com/propublicas-charles-ornstein-on-life-beyond-sunshine/article/284446/</link>
          <pubDate>Thu, 14 Mar 2013 18:34:27 GMT</pubDate>
          <itunes:summary>What will become of Dollars for Docs after the Sunshine provisions go into effect? We asked Charles Ornstein, who told us what&apos;s next for the project.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>CMS releases &quot;Sunshine&quot; final rule: federal preemption, August start date</title>
          <description>CMS issued its long-delayed final rule for collecting data on industry payments to physicians, ordering data collection to begin in August and asserting that the federal law preempts state laws.</description>
          <link>http://www.mmm-online.com/cms-releases-sunshine-final-rule-federal-preemption-august-start-date/article/278783/</link>
          <pubDate>Fri, 01 Feb 2013 21:20:35 GMT</pubDate>
          <itunes:summary>CMS issued its long-delayed final rule for collecting data on industry payments to physicians, ordering data collection to begin in August and asserting that the federal law preempts state laws.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>For Bay State, &quot;modest meals&quot; are in the eye of the beholder</title>
          <description>As the Massachusetts Department of Public Health deliberates the exact shape of a rule change allowing industry-sponsored meals for physicians in speaker programs, pharma foes and industry advocates are squaring off over the definition of &quot;modest meals and refreshments.&quot;</description>
          <link>http://www.mmm-online.com/for-bay-state-modest-meals-are-in-the-eye-of-the-beholder/article/265416/</link>
          <pubDate>Thu, 25 Oct 2012 19:02:17 GMT</pubDate>
          <itunes:summary>As the Massachusetts Department of Public Health deliberates the exact shape of a rule change allowing industry-sponsored meals for physicians in speaker programs, pharma foes and industry advocates are squaring off over the definition of &quot;modest meals and refreshments.&quot;</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  